NDC 42291-922 – Theophylline
Theophylline Anhydrous 300 mg/1 · Tablet, Extended Release · Oral
Product NDC42291-922
Product details
- Brand name
- Theophylline
- Generic name
- Theophylline
- Labeler
- AvKARE
- Dosage form
- Tablet, Extended Release
- Route
- Oral
- Marketing category
- ANDA · ANDA089763
- Marketed since
- April 13, 2023
- Listing expires
- December 31, 2027
- Pharmacologic class
- Methylxanthine
Active ingredients
- Theophylline Anhydrous 300 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 42291-922-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (42291-922-01) | Apr 13, 2023 |
Other Theophylline products
- 27241-272 Theophylline Anhydrous 300 mg/1 · Tablet, Extended Release · Ajanta Pharma USA Inc.
- 27241-273 Theophylline Anhydrous 450 mg/1 · Tablet, Extended Release · Ajanta Pharma USA Inc.
- 62332-025 Theophylline Anhydrous 300 mg/1 · Tablet, Extended Release · Alembic Pharmaceuticals Inc.
- 62332-026 Theophylline Anhydrous 450 mg/1 · Tablet, Extended Release · Alembic Pharmaceuticals Inc.
- 46708-026 Theophylline Anhydrous 450 mg/1 · Tablet, Extended Release · Alembic Pharmaceuticals Limited
- 46708-025 Theophylline Anhydrous 300 mg/1 · Tablet, Extended Release · Alembic Pharmaceuticals Limited
- 60219-2046 Theophylline Anhydrous 450 mg/1 · Tablet, Extended Release · Amneal Pharmaceuticals LLC
- 60219-2045 Theophylline Anhydrous 300 mg/1 · Tablet, Extended Release · Amneal Pharmaceuticals LLC
- 69452-267 Theophylline Anhydrous 300 mg/1 · Tablet, Extended Release · Bionpharma Inc.,
- 31722-077 Theophylline Anhydrous 300 mg/1 · Tablet, Extended Release · Camber Pharmaceuticals, Inc.
- 31722-078 Theophylline Anhydrous 450 mg/1 · Tablet, Extended Release · Camber Pharmaceuticals, Inc.
- 62135-457 Theophylline Anhydrous 300 mg/1 · Tablet, Extended Release · Chartwell RX, LLC